The companies will collaborate with biopharmaceutical partners for exploratory panel development and FDA approval of diagnostic and IVD kit manufacturing and distribution, BD said Aug. 9.
Flow cytometry is most commonly used in diagnostics for analyzing bone marrow, blood and other bodily fluids. It can detect the patterns of antigens on cells, which may indicate the presence of leukemia, lymphoma or other diseases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
